Praxis Precision Medicines
Clinical trials sponsored by Praxis Precision Medicines, explained in plain language.
-
Epilepsy drug vormatrigine moves to long-term safety check in 700 adults
Disease control ENROLLING_BY_INVITATIONThis study is checking the long-term safety of the drug vormatrigine in 700 adults who have epilepsy with focal or generalized tonic-clonic seizures. All participants have already taken vormatrigine in a previous study. The main goal is to see how safe and tolerable the drug is o…
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New hope for kids with rare epilepsy: drug trial targets seizures
Disease control OngoingThis study tests an experimental drug called PRAX-562 in 77 children with rare genetic epilepsies (SCN2A or SCN8A) that cause severe seizures starting in infancy. The goal is to see if the drug is safe and can reduce monthly motor seizures. The trial has a double-blind phase foll…
Phase: PHASE2, PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated May 18, 2026 11:58 UTC
-
New pill could steady shaky hands in essential tremor
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a new drug called ulixacaltamide can safely reduce tremors in adults with essential tremor, a condition that causes shaking hands. About 1,000 participants will receive either the drug or a placebo for up to 12 weeks, and then may join a longer safety stu…
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Symptom relief
Last updated May 26, 2026 07:42 UTC